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Background
HLA-B*35-Px subtypes are associated with accelerated
HIV-1 disease courses, in contrast to HLA-B*35-PY sub-
types which do not have any detectable impact on HIV-1
disease, although they differ in as few as one amino acid.
The mechanisms accounting for the differential influence
of HLA-B*35 subtypes on HIV-1 disease progression
remain unclear. ILT4 is an inhibitory HLA class I receptor
that is upregulated during HIV-1 infection and can criti-
cally regulate the functional profile of DCs.
Methods
To test whether HIV-1 CTL epitopes presented by alterna-
tive HLA-B*35 subtypes are differentially recognized by
ILT4, we used recombinant HLA-B*3501 (PY) and -
B*3503 (Px) tetramers refolded with two dominant B*35-
restricted epitopes to stain mDC from HIV-1 infected indi-
viduals. Functional consequences of the altered recogni-
tion of these tetramers by ILT4 were performed using mix
lymphocyte reaction.
Results
HLA-B*3503 complexes had significantly higher (p =
0.01) ILT4-mediated binding intensities to mDC, com-
pared to the respective p/B*3501 complexes refolded with
identical epitopes. Biacore experiments confirmed a sig-
nificantly higher binding affinity between recombinant
ILT4 and HLA-B35-Px molecules compared to HLA-B35-
PY molecules. Higher recognition of the B*35-Px com-
plexes by ILT4 led to DC dysfunction and significantly
impaired the proliferation of allogeneic T cells (p =
0.0027) compared to B*35-PY tetramers; this effect could
be reversed by si-RNA-mediated ILT4 knockdown. Ex vivo
MLR assays showed that mDCs isolated from HIV-1
infected carriers of HLA-B*35-Px had a significantly
weaker capacity for allogeneic T cell expansion compared
to DCs from B*35-PY carriers (p = 0.002).
Conclusion
Inhibitory impulses resulting from preferential recogni-
tion of B*35-Px subtypes by ILT4 and subsequent DC dys-
function might contribute to the accelerated HIV-1
disease progression associated with HLA-B*35-Px sub-
types. Differential interactions between HLA class I alleles
and immunoregulatory MHC class I receptors on DCs
provide a novel perspective for the understanding of how
MHC class I impact HIV-1 disease progression.
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